This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Foreign Product Alerts: Aisiyuan V26 Slimming Granules, AcaiBerry Living-XS, and 4C Cosmoslim
- Starting date:
- November 8, 2013
- Posting date:
- November 8, 2013
- Type of communication:
- Foreign Product Alert (FPA)
- Subcategory:
- Natural health products
- Source of recall:
- Health Canada
- Issue:
- Undeclared Substance
- Audience:
- General Public
- Identification number:
- RA-36269
Introduction
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
Affected products
- Aisiyuan V26 Slimming Granules
- AcaiBerry Living-XS
- 4C Cosmoslim
Aisiyuan V26 Slimming Granules
Product description
This product is promoted for weight loss.
Hazard identified
The Hong Kong Department of Health has warned consumers not to use this product as it contains sibutramine, a drug ingredient that is not declared on the product label.
- Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke.
Place of origin
Unknown
Side effects
In addition to heart attack and stroke, side-effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.
AcaiBerry Living-XS and 4C Cosmoslim
Product description
These products are promoted for weight loss.
Hazard identified
The Hong Kong Department of Health has warned consumers not to use AcaiBerry Living-XS and 4C Cosmoslim as they contain sibutramine and phenolphthalein, drug ingredients that are not declared on the product label.
- Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke.
- Phenolphthalein was previously used as a laxative but is no longer authorized for sale in Canada because it may cause cancer.
Place of origin
Unknown
Side effects
In addition to heart attack and stroke, side-effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.
Additional side-effects associated with phenolphthalein include decreased blood pressure, skin rash and gastrointestinal bleeding.
What you should do
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the products listed above in the Canadian marketplace.
Background
Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of October 25, 2013, no adverse reactions suspected to be associated with the use of these products have been reported to Health Canada.
Report a health or safety concern
- Call toll-free at 1-866-234-2345
- Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax
Media enquiries
Health Canada
(613) 957-2983
Public enquiries
(613) 957-2991
1-866 225-0709
Images
Select thumbnail to enlarge - opens in a new window